Raymond James initiated coverage on Third Harmonic Bio with a new price target
$THRD
Biotechnology: Pharmaceutical Preparations
Health Care
Raymond James initiated coverage of Third Harmonic Bio with a rating of Outperform and set a new price target of $18.00